Related Experiment Videos
Resistant microorganisms in head and neck infections
1Department of Microbiology, Mount Sinai Hospital,Toronto, ON. tmazzulli@mtsinai.on.ca
The Journal of Otolaryngology
|August 11, 2005
Summary
Antimicrobial resistance is increasing in common upper respiratory tract pathogens like Streptococcus pneumoniae. Prudent antibiotic use is crucial to combat evolving resistance and improve patient outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Common upper respiratory tract infections are caused by key pathogens including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes.
- Antimicrobial resistance in these bacteria is a growing concern, impacting treatment efficacy.
- Mechanisms of resistance vary, with beta-lactamase production being standard in M. catarrhalis.
Purpose of the Study:
- To review the evolving landscape of antimicrobial resistance in common respiratory pathogens.
- To highlight the role of antibiotic overuse and misuse in driving resistance.
- To emphasize the importance of considering resistance when selecting empiric therapy.
Main Methods:
- Literature review of antimicrobial resistance trends in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes.
- Analysis of resistance mechanisms and prevalence.
- Discussion of factors contributing to resistance, such as antibiotic overuse.
Main Results:
- Antimicrobial resistance is rising in S. pneumoniae.
- S. pyogenes has not shown resistance to penicillin.
- Over 90% of M. catarrhalis isolates produce beta-lactamase, rendering them resistant to many beta-lactam antibiotics.
- Antibiotic overuse and misuse in the community are major drivers of resistance.
Conclusions:
- Considering antimicrobial resistance is essential for selecting appropriate empiric therapy for respiratory infections.
- Appropriate antibiotic use is critical to mitigate the escalating problem of antimicrobial resistance.
- Further research may be needed to clarify the clinical impact of resistance on patient outcomes.